Corporate Sites
https://www.oncopeptides-us.com/en
Contact in CT:
Important News and Information
FDA Approves Oncopeptides´ PEPAXTO® (melphalan flufenamide) for Patients with Triple-Class Refractory Multiple Myeloma 03/01/2021
c/o Dawn Holcombe
dawnho@aol.com
33 Woodmar Circle South Windsor, CT 06074 (860) 305-4510
Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds